Pharma & Biotech
Small caps
Director Interviews
Small caps
Shield Therapeutics supported in negotiations with prospective US partners by new findings, says Peel Hunt
Analysts say completing the negotiations represents significant further upside potential for the...
Danish giant Novo Nordisk recently signed up to use its NDD platform, and bosses expect more...
Below we take a closer look at Shield Therapeutics...
Turner Pope's Andy Thacker said there has been a boom in investor demand for firms in the...
TZLS-501 is a class of monoclonal antibody (mAb) called an anti-interleukin-6 receptor, or...
Dr James Khodabakhsh MD speaks to Proactive's Andrew Scott following his appointment as chair of OKYO Pharma Limited's (LON:OKYO) Scientific Advisory Board. He'll be tasked with bringing together a small group of leaders to review and inform the company's plans to progress its lead product...
Pharma & Biotech
Amryt Pharma releases Q-2 financials that show strong revenue...
Pharma & Biotech
Tiziana Life Sciences PLC's clinical plan is shaping up says...
Pharma & Biotech
Redx Pharma PLC in a great place to move forward after Astra deal...
Market Report
Get our market previews and stories before the main networks.
Not just the FTSE. Read about
opportunities from the whole
equities market.
Hear directors at first-hand
or meet them in person at our events.
Watch IPOs and access on the same terms as the institutions.
